Results 171 to 180 of about 38,787 (243)

Co‐Designing a Digital Health Application for Assisting Self‐Care Diabetes Patients: A Qualitative Study

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Managing diabetes involves complex self‐care activities, requiring continuous support. Although digital health applications have shown promise, many fail to meet patients' sustained needs. This study aims to understand the needs and preferences of patients for co‐designing a digital health application focused on diabetes ...
Hema Malini   +4 more
wiley   +1 more source

Artificial intelligence for personalized multiple micronutrient supplementation in maternal health

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 173, Issue 3, Page 1163-1173, June 2026.
Abstract Maternal undernutrition and micronutrient deficiencies remain pervasive, contributing to adverse pregnancy outcomes and long‐term health risks for mothers and offspring. Multiple micronutrient supplementation (MMS) during pregnancy has demonstrated benefits, including reduced risks of low birth weight, small‐for‐gestational‐age births, and ...
Gabriel Davis Jones   +9 more
wiley   +1 more source

Fully Synthetic, Biomimicking Polysulfates With Tunable Anticoagulant and Endothelial Cell–Selective Bioactivity

open access: yesMacromolecular Bioscience, Volume 26, Issue 6, June 2026.
Sulfated PHEMA‐based polyelectrolyte brushes are introduced as a reductionist platform to probe glycosaminoglycan‐inspired bioactivity. High charge density governs growth factor interactions and is associated with distinct vascular cell responses, enabling balanced endothelial and smooth muscle cell co‐culture.
Andrea Cosimi   +9 more
wiley   +1 more source

Innovative Drug Delivery Systems for the Treatment of Glaucoma

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.
This review aims to provide a comprehensive overview of current topical drug delivery strategies for ocular hypotensive agents in glaucoma therapy. Additionally, it discusses the potential impact of emerging nanotechnological and biomaterial‐based systems in shaping the future of ophthalmic drug delivery, with an emphasis on enhancing efficacy, safety,
Jing Chu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy